ReviewMayo Clinic proceedings2020
Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook.
Review in Mayo Clinic proceedings, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
73 citing papers in PubMed, 1 synthesis or guideline pooled it, 129 citations in OpenAlex.
- Effects of brief substance use interventions delivered in general medical settings: a systematic review and meta-analysis.Addiction (Abingdon, England) · 2022Pooled it
- Trial
- Effect of Electronic Portal Messaging With Embedded Asynchronous Care on Physician-Assisted Smoking Cessation Attempts: A Randomized Clinical Trial.JAMA network open · 2022Trial
- Comparing the effectiveness of in-person vs. virtual intensive group interventions for healthcare professionals with substance use disorders.Substance abuse treatment, prevention, and policy · 2026Article
- Digital Therapeutic Content for Substance Use Disorder Treatment: Development and Evaluation Study.JMIR formative research · 2026Article
- A longitudinal analysis of overall and telehealth addiction treatment utilization three years after pandemic-related policy changes.Journal of substance use and addiction treatment · 2026Article
- State Medicaid Telehealth Policies and Rates of Alcohol and Substance Use Treatment at Federally Qualified Health Centers: Does Modality Matter?Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2026Article
- Digital Therapies for Substance Use Disorders: Recent Advances and Engagement Strategies.Substance abuse and rehabilitation · 2026Review
- Geographic and Policy Factors Influence Telehealth Availability for Substance Use Disorder Treatment.The journal of behavioral health services & research · 2026Article
- Implementation outcomes of video-observed oral fluid self-collection for drug testing in substance use disorder treatment: a pilot study.Frontiers in public health · 2026Article
- Facilitator perspectives on in-person versus videoconference delivery of a remedial intervention for impaired drivers: a qualitative study.Addiction science & clinical practice · 2025Article
- Mining Social Media for Barriers to Opioid Recovery with LLMs.Proceedings of the ... Workshop on Patient-Oriented Language Processing · 2025Article
- Treatment of Substance Use Disorders With a Mobile Phone App Within Rural Collaborative Care Management (Senyo Health): Protocol for a Mixed Methods Randomized Controlled Trial.JMIR research protocols · 2025Article
- Global, regional and national burden of drug use disorders, 1990-2021: decomposition analysis, health inequality analysis and predictions to 2035.Frontiers in public health · 2025Article
- Hybrid Virtual Group Model for Substance Use Disorder Therapy: A Scoping Review.Substance abuse and rehabilitation · 2025Review
- Telehealth Disparities in Outpatient Substance Use Disorder (SUD) Treatment among Medicaid Beneficiaries during COVID-19.Substance use & misuse · 2025Article
- Patient Engagement in Providing Telehealth SUD IOP Treatment: A Retrospective Cohort Study.Healthcare (Basel, Switzerland) · 2024Article
- A quarantine paradox: understanding Gender-Based Violence (GBV) in post-COVID-19 era: insights from Golden Valley mining community, Zimbabwe.BMC public health · 2024Article
- Patients' and Clinicians' Experiences with In-person, Video, and Phone Modalities for Opioid Use Disorder Treatment: A Qualitative Study.Journal of general internal medicine · 2024Article
- Therapeutic Content of Mobile Phone Applications for Substance Use Disorders: An Umbrella Review.Mayo Clinic proceedings. Digital health · 2024Article
13 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During the current coronavirus disease 2019 epidemic, many outpatient chemical dependency treatment programs and clinics are decreasing their number of in-person patient contacts. This has widened an already large gap between patients with substance use disorders (SUDs) who need treatment and those who have actually received treatment. For a disorder where group therapy has been the mainstay treatment option for decades, social distancing, shelter in place, and treatment discontinuation have created an urgent need for alternative approaches to addiction treatment. In an attempt to continue some care for patients in need, many medical institutions have transitioned to a virtual environment to promote safe social distancing. Although there is ample evidence to support telemedical interventions, these can be difficult to implement, especially in the SUD population. This article reviews current literature for the use of telehealth interventions in the treatment of SUDs and offers recommendations on safe and effective implementation strategies based on the current literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.